[go: up one dir, main page]

AU2002350245A1 - Mhyps as modifiers of branching morphogenesis and methods of use - Google Patents

Mhyps as modifiers of branching morphogenesis and methods of use

Info

Publication number
AU2002350245A1
AU2002350245A1 AU2002350245A AU2002350245A AU2002350245A1 AU 2002350245 A1 AU2002350245 A1 AU 2002350245A1 AU 2002350245 A AU2002350245 A AU 2002350245A AU 2002350245 A AU2002350245 A AU 2002350245A AU 2002350245 A1 AU2002350245 A1 AU 2002350245A1
Authority
AU
Australia
Prior art keywords
mhyps
modifiers
methods
branching morphogenesis
morphogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002350245A
Other versions
AU2002350245A8 (en
Inventor
Thierry T. Diagana
Felix D. Karim
Gregory D. Plowman
Lisa Ryner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of AU2002350245A8 publication Critical patent/AU2002350245A8/en
Publication of AU2002350245A1 publication Critical patent/AU2002350245A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002350245A 2001-11-26 2002-11-25 Mhyps as modifiers of branching morphogenesis and methods of use Abandoned AU2002350245A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33337201P 2001-11-26 2001-11-26
US33338601P 2001-11-26 2001-11-26
US60/333,372 2001-11-26
US60/333,386 2001-11-26
PCT/US2002/037633 WO2003045314A2 (en) 2001-11-26 2002-11-25 Mhyps as modifiers of branching morphogenesis and methods of use

Publications (2)

Publication Number Publication Date
AU2002350245A8 AU2002350245A8 (en) 2003-06-10
AU2002350245A1 true AU2002350245A1 (en) 2003-06-10

Family

ID=26988699

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002350245A Abandoned AU2002350245A1 (en) 2001-11-26 2002-11-25 Mhyps as modifiers of branching morphogenesis and methods of use

Country Status (2)

Country Link
AU (1) AU2002350245A1 (en)
WO (1) WO2003045314A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004254590A1 (en) * 2003-06-19 2005-01-13 Exelixis, Inc. MYLKs as modifiers of branching morphogenesis and methods of use
WO2005072470A2 (en) * 2004-01-28 2005-08-11 Exelixis, Inc Mbms as modifiers of branching morphogenesis and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235033A (en) * 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5840532A (en) * 1997-01-21 1998-11-24 Board Of Regents, The University Of Texas System Neuronal bHLH-PAS domain proteins
US5837283A (en) * 1997-03-12 1998-11-17 The Regents Of The University Of California Cationic lipid compositions targeting angiogenic endothelial cells

Also Published As

Publication number Publication date
AU2002350245A8 (en) 2003-06-10
WO2003045314A3 (en) 2003-11-13
WO2003045314A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2003220586A1 (en) Game piece and system and method of use
AU2002314466A1 (en) Withasol and methods of use
AU2002306768A1 (en) Expression profiles and methods of use
AU2002310256A1 (en) Ppp2cs as modifiers of the p53 pathway and methods of use
AU2002257936A1 (en) Methods of well treatment
AU2002335085A1 (en) Angiopoietins and methods of use thereof
AUPR301001A0 (en) Compression garments and methods of use
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2002359476A1 (en) MAP4Ks AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
AU2002359474A1 (en) MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2003284324A1 (en) Ccr8 as modifier of branching morphogenesis and methods of use
AU2002362020A1 (en) CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE
AU2002350245A1 (en) Mhyps as modifiers of branching morphogenesis and methods of use
AU2003248881A1 (en) Snrks as modifiers of chk and branching morphogenesis and methods of use
AU2002355432A1 (en) Kavalactone compositions and methods of use
EP1664337A4 (en) MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
AU2003272449A1 (en) MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
AU2002332130A1 (en) Msrebps as modifiers of the srebp pathway and methods of use
WO2003016502A9 (en) Tramdorins and methods of using tramdorins
EP1664288A4 (en) Mylks as modifiers of branching morphogenesis and methods of use
AU2002361654A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2002359696A1 (en) Vps41s as modifiers of cell death and methods of use
AU2002240236A1 (en) Endoscope system and method of use
AU2002229417A1 (en) Compression garments and method of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase